A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CBNK SEC filings page.
Capital Bancorp, Inc. (CBNK) reported $253.9M in revenue over the twelve months to Jun 30, 2026, up 15.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Capital Bancorp’s balance-sheet-funded model produced a 2025 earnings and cash rebound that outpaced asset growth.
Cash conversion strengthened alongside profitability: FY2025 operating cash flow reached$69.7M against net income of$57.2M , a relationship that indicates reported earnings were translating into cash. That conversion was better than FY2024, when operating cash flow was$34.9M versus net income of$31.0M .
Liability-funded scale remains structural: liabilities represented
Profitability improved faster than the franchise footprint: revenue increased
Financial Health Signals
Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Capital Bancorp, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Capital Bancorp, Inc. earned a return on assets of 1.6% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 1.0% the prior year. Earnings ranks banks on that return over three years, and Capital Bancorp, Inc. scores 84/100 among other banks.
Capital Bancorp, Inc. reported revenue of $245.2M in fiscal year 2025, against $186.2M in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Capital Bancorp, Inc. scores 80/100 among other banks.
Capital Bancorp, Inc. funded 11.1% of its assets with shareholders' equity at the end of fiscal year 2025, holding $401.8M of equity against $3.6B of assets. Capital ranks banks on that cushion, and Capital Bancorp, Inc. scores 49/100 among other banks.
Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Capital Bancorp, Inc. scores 46/100 on it among other banks.
Not available for Capital Bancorp, Inc., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.
Capital Bancorp, Inc. reported net income of $57.2M in fiscal year 2025, against $31.0M in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Capital Bancorp, Inc. scores 56/100 among other banks.
Capital Bancorp, Inc. passes 6 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
Key Financial Metrics
Earnings & Revenue
Capital Bancorp, Inc. generated $65.3M in revenue in Q2 2026. This represents an increase of 7.5% from the same quarter a year earlier. Against the prior quarter it is up 4.0%.
Capital Bancorp, Inc. reported $14.3M in net income in Q2 2026. This represents an increase of 8.5% from the same quarter a year earlier. Against the prior quarter it is up 18.6%.
Capital Bancorp, Inc. earned $0.87 per diluted share (EPS) in Q2 2026. This represents an increase of 11.5% from the same quarter a year earlier. Against the prior quarter it is up 19.2%.
Not reported for Q2 2026.
Cash & Balance Sheet
Capital Bancorp, Inc. held $418.3M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Capital Bancorp, Inc. paid $0.12 per share in dividends in Q2 2026. This represents an increase of 20.0% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Margins & Returns
Capital Bancorp, Inc.'s net profit margin was 21.8% in Q2 2026, showing the share of revenue converted to profit. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.
Capital Bancorp, Inc.'s quarterly ROE was 3.4% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.4 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Capital Bancorp, Inc. spent $36K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 98.7% from the same quarter a year earlier. Against the prior quarter it is down 99.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
CBNK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3M+7.5% | $62.8M+7.1% | $62.7M+11.6% | $63.1M+40.2% | $60.8M+38.2% | $58.6M+43.0% | $56.2M+37.8% | $45.0M+4.3% |
| Operating Income | N/A | N/A | N/A | -$923Kn/m | -$933Kn/m | -$903Kn/m | -$993Kn/m | -$1.0Mn/m |
| Interest Expense | $19.0M+12.3% | $18.6M+11.1% | $18.4M+5.6% | $12.9M-9.7% | $16.9M+24.9% | $16.7M+25.1% | $17.4M+43.9% | $14.3M+30.4% |
| Income Tax | $4.2M+6.1% | $3.9M-11.7% | $4.6M+43.2% | $4.8M+69.9% | $4.0M+45.3% | $4.4M+111.7% | $3.2M+48.4% | $2.8M-5.7% |
| Net Income | $14.3M+8.5% | $12.0M-13.7% | $15.0M+99.6% | $15.1M+73.7% | $13.1M+60.1% | $13.9M+112.3% | $7.5M-16.6% | $8.7M-11.4% |
| EPS (Basic) | $0.87+10.1% | $0.74-11.9% | $0.91+111.6% | $0.91+46.8% | $0.79+33.9% | $0.84+78.7% | $0.43-33.8% | $0.62-11.4% |
| EPS (Diluted) | $0.87+11.5% | $0.73-11.0% | $0.91+111.6% | $0.89+43.5% | $0.78+32.2% | $0.82+74.5% | $0.43-33.8% | $0.62-11.4% |
| Diluted Shares (Avg) | 16M-2.6% | 16M-2.9% | N/A | 17M+20.7% | 17M+20.9% | 17M+21.6% | N/A | 14M-0.5% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA.
CBNK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.9B+14.8% | $3.8B+13.7% | $3.6B+12.5% | $3.4B+32.4% | $3.4B+39.0% | $3.3B+44.1% | $3.2B+44.1% | $2.6B+12.7% |
| Cash & Equivalents | $418.3M+52.3% | $399.3M+35.8% | $255.6M+24.5% | $188.9M+20.5% | $274.6M+101.2% | $294.0M+245.0% | $205.3M+280.5% | $156.7M+7.2% |
| Goodwill | $26.0M+15.5% | $26.0M+7.8% | $26.0M+22.9% | $26.0Mn/m | $22.5Mn/m | $24.1M | $21.1Mn/m | $0 |
| Total Liabilities | $3.5B+15.3% | $3.4B+14.1% | $3.2B+12.4% | $3.0B+31.3% | $3.0B+38.6% | $3.0B+44.3% | $2.9B+44.7% | $2.3B+12.4% |
| Total Equity | $422.2M+11.1% | $408.9M+10.6% | $401.8M+13.1% | $394.8M+40.9% | $380.0M+41.9% | $369.6M+42.4% | $355.1M+39.3% | $280.1M+15.3% |
| Retained Earnings | $315.1M+20.7% | $302.8M+21.2% | $292.7M+20.5% | $274.0M+17.6% | $261.1M+15.6% | $249.9M+14.3% | $242.9M+13.8% | $233.0M+13.1% |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
CBNK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5.0Mn/m | $21.8M-3.6% | $18.5M-28.8% | $32.9Mn/m | -$4.2M-132.7% | $22.6Mn/m | $25.9M+318.3% | -$464K-102.1% |
| Stock-Based Compensation | N/A | $512K+25.8% | N/A | N/A | N/A | $407K-13.8% | N/A | N/A |
| Investing Cash Flow | -$53.1Mn/m | -$72.1Mn/m | -$141.4Mn/m | -$88.1Mn/m | -$60.3Mn/m | -$61.1Mn/m | -$63.1Mn/m | -$83.7Mn/m |
| Financing Cash Flow | $77.1M+70.8% | $194.0M+52.6% | $189.7M+121.1% | -$30.6M-129.3% | $45.1M-56.6% | $127.2M+37.8% | $85.8Mn/m | $104.4M+240.8% |
| Dividends Paid | $2.0M+17.9% | $2.0M+17.6% | $2.0M+19.6% | $2.0M+43.1% | $1.7M+49.1% | $1.7M+49.4% | $1.7M+49.0% | $1.4M+24.8% |
| Share Buybacks | $36K-98.7% | $3.6M+475.6% | $8.6Mn/m | -$312Kn/m | $2.9Mn/m | $618K-55.8% | $0-100.0% | $0-100.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow.
CBNK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | -1.5%+0.8pp | -1.5%+0.2pp | -1.5%+0.7pp | -1.8%+1.9pp | -2.2%0.0pp |
| Net Margin | 21.8%+0.2pp | 19.1%-4.6pp | 24.0%+10.6pp | 23.9%+4.6pp | 21.6%+2.9pp | 23.8%+7.8pp | 13.4%-8.7pp | 19.3%-3.4pp |
| Return on Equity | 3.4%-0.1pp | 2.9%-0.8pp | 3.7%+1.6pp | 3.8%+0.7pp | 3.5%+0.4pp | 3.8%+1.2pp | 2.1%-1.4pp | 3.1%-0.9pp |
| Return on Assets | 0.4%0.0pp | 0.3%-0.1pp | 0.4%+0.2pp | 0.4%+0.1pp | 0.4%+0.1pp | 0.4%+0.1pp | 0.2%-0.2pp | 0.3%-0.1pp |
| Liabilities-to-Equity | 8.21+0.3x | 8.31+0.3x | 7.98-0.1x | 7.59-0.6x | 7.92-0.2x | 8.06+0.1x | 8.03+0.3x | 8.14-0.2x |
| Asset Turnover | 0.020.0x | 0.020.0x | 0.020.0x | 0.020.0x | 0.020.0x | 0.020.0x | 0.020.0x | 0.020.0x |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio, Debt-to-Equity, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Capital Bancorp, Inc. CBNK | FY2025 | $245.2M | $57.2M | 23.3% | $679.4M | 63/100 |
| South Plains Financial, Inc. SPFI | FY2025 | $211.9M | $58.5M | 27.6% | $810.5M | 57/100 |
| Bar Harbor Bankshares BHB | FY2025 | $168.9M | $36.9M | 21.9% | $678.4M | 57/100 |
| Unity Bancorp UNTY | FY2025 | $131.8M | $58.0M | 44.0% | $585.4M | 74/100 |
| Shore Bancshares Inc SHBI | FY2025 | $225.1M | $59.5M | 26.4% | $765.6M | 42/100 |
Where Capital Bancorp, Inc. Ranks
Frequently Asked Questions
What is Capital Bancorp, Inc.'s annual revenue?
Capital Bancorp, Inc. (CBNK) reported $245.2M in total revenue for fiscal year 2025. This represents a 31.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Capital Bancorp, Inc.'s revenue growing?
Capital Bancorp, Inc. (CBNK) revenue grew by 31.7% year-over-year, from $186.2M to $245.2M in fiscal year 2025.
Is Capital Bancorp, Inc. profitable?
Yes, Capital Bancorp, Inc. (CBNK) reported a net income of $56.4M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $57.2M, with a net profit margin of 23.3%.
What is Capital Bancorp, Inc.'s net profit margin?
Capital Bancorp, Inc. (CBNK) had a net profit margin of 23.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Capital Bancorp, Inc. pay dividends?
Yes, Capital Bancorp, Inc. (CBNK) paid $0.44 per share in dividends during fiscal year 2025.
What is Capital Bancorp, Inc.'s return on equity (ROE)?
Capital Bancorp, Inc. (CBNK) has a return on equity of 14.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Capital Bancorp, Inc.'s operating cash flow?
Capital Bancorp, Inc. (CBNK) generated $69.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Capital Bancorp, Inc.'s total assets?
Capital Bancorp, Inc. (CBNK) had $3.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Capital Bancorp, Inc.'s liabilities-to-equity ratio?
Capital Bancorp, Inc. (CBNK) had a liabilities-to-equity ratio of 7.98 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is Capital Bancorp, Inc.'s return on assets (ROA)?
Capital Bancorp, Inc. (CBNK) had a return on assets of 1.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Capital Bancorp, Inc.'s P/E ratio?
Capital Bancorp, Inc. (CBNK) trades at 12.1x earnings, its market capitalization divided by $56.4M net income, trailing 12 months to June 30, 2026. The market capitalization is $679.4M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Capital Bancorp, Inc.'s price-to-sales ratio?
Capital Bancorp, Inc. (CBNK) trades at 2.7x sales, its market capitalization divided by $253.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $679.4M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Capital Bancorp, Inc.'s Piotroski F-Score?
Capital Bancorp, Inc. (CBNK) has a Piotroski F-Score of 6 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
How financially healthy is Capital Bancorp, Inc.?
Capital Bancorp, Inc. (CBNK) scores 63 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is the average of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Capital Bancorp, Inc. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.